JANX

Conviction 60HealthcareScan · Mon, Aug 10, 2026

JANX$16.41+3.50%

ResistanceSupportVol 14Insider sell

Vol MA14 815.05K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Janux Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.januxrx.com ↗

Price16.41

Change+3.50%

Gap-0.13%

Rel volume2.99×

Avg volume803.73K

Avg $ vol12.71M

SMA 2015.74

SMA 5015.07

SMA 20016.51

Price vs 50+8.87%

Price vs 200-0.61%

MA stackmixed

50/200 cross—

Supertrendup · 14.65

RSI (14)59

MACD hist0.03

MACD crossbull · 0d

Stoch %K / %D89 / 79

ADX (14)14

+DI / −DI24 / 15

RSI divergence—

MACD divergence—

ATR %+3.88%

ADR %3.99%

52w high34.74

52w low12.18

From 52w high-52.78%

Above 52w low+34.69%

New 52w highNo

SqueezeOn · 2d

Bollinger width10.37%

%B0.91

Donchian pos88.86%

Donchian high16.64

Donchian low14.57

AVWAP (52w high)15.11

vs AVWAP high+8.54%

AVWAP (52w low)14.50

vs AVWAP low+13.13%

OBV trendUp

Chaikin MF (20)0.04

Today vs 20d2.99×

Avg vol (14d)815.05K

Avg vol (20d)803.73K

Avg $ vol (20d)12.71M

Market cap1B

RS 3m (vs SPY)+3.31%

RS 6m (vs SPY)+16.02%

RS line new highNo

Trend template3/8

Technical rank64.5

1 week+7.08%

1 month+0.03%

3 months+15.73%

6 months+25.52%

1 year-27.35%

YTD+20.18%

P/E-8.83

P/B1.08

P/S100.29

P/FCF-12.04

EPS-1.83

Div yield—

ROE-12.24%

ROA-11.28%

Debt/Eq—

Current16.35

EV/EBITDA—

Gross margin—

Net margin—

Rev growth-5.55%

EPS growth-64.69%

Price target34.11

Target upside107.92%

Analyst ratingBuy

Institutional105.66%

Ent. value975.18M

Revenue10.27M

Net income-21.97M

Gross profit—

Free cash flow-83.28M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out60.98M

Employees108

ListedFri, Jun 11, 2021

Free float37.06M

Float %61.6%

Short interest6.45M

Days to cover6.4d

Short volume42.2%

Squeeze score76 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.35 vs −$0.26

Last surprise-34.6% miss

Setup gradeB

Conviction60 / 100

Pattern quality—

Tech rank64.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance16.72

Support14.54

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jun 22
1 scan
→
Breaking out now
Jun 23
1 scan
→
Broke out
Jun 24
1 scan
→
Setting up
Jun 25
1 scan
→
Breaking out now
Jun 26
1 scan
→
Broke out
Jun 29
1 scan
→
Setting up
Jul 21
1 scan

Congress activity

Disclosed STOCK Act trades in JANX

All disclosures →

No recent disclosed trades by Congress in JANX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in JANX · 3 buys · 3 sells

Insider	Side	Shares	Value	Traded	Filed
Campbell David Alan President and CEO · Common Stock · 2026-07-08	Exercise	7K	$29K	2026-07-08	2026-07-10
Campbell David Alan President and CEO · Stock Option (right to buy) · 2026-07-08	Exercise	7K	—	2026-07-08	2026-07-10
Barrett Ronald W Director · Common Stock · 2026-06-11	Grant	5.5K	—	2026-06-11	2026-06-12
Barrett Ronald W Director · Stock Option (right to buy) · 2026-06-11	Grant	15.5K	—	2026-06-11	2026-06-12
Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr · Common Stock · 2026-06-02	Sell	4.06K	$57K	2026-06-02	2026-06-04
Dobek Maria Vice President, Accounting · Common Stock · 2026-05-11	Sell	2.04K	$29K	2026-05-11	2026-05-13

SEC filings

EDGAR filings in JANX · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.